NEW YORK (360Dx) – Beckman Coulter Diagnostics and Diazyme Laboratories today announced the US Food and Drug Administration cleared Beckman Coulter's procalcitonin assay.

The assay is the first homogeneous PCT assay for use on Beckman Coulter AU model chemistry analyzers and can be used to manage bacterial infections and sepsis. The fully automated assay, which features a latex-enhanced immunoturbidimetric methodology based on antibodies for enhanced sensitivity and specificity, can be used with Beckman Coulter AU analyzers, models 480, 680, and 5800.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.